Protein family
Protein sequence
Protein function
Catalytic activity
EC number
EC number description
2.3.1.-
Transferases;
Acyltransferases;
Transferring groups other than aminoacyl groups;
2.3.1.48
Transferases;
Acyltransferases;
Transferring groups other than aminoacyl groups;
histone acetyltransferase
PDB | Resolution (Å) | PDB name |
---|---|---|
1L3E | NMR Structures of the HIF-1alpha CTAD/p300 CH1 Complex | |
1P4Q | Solution structure of the CITED2 transactivation domain in complex with the p300 CH1 domain | |
2K8F | Structural Basis for the Regulation of p53 Function by p300 | |
2MH0 | Solution NMR structure of the p300 Taz2:ETAD1 complex | |
2MZD | Characterization of the p300 Taz2-p53 TAD2 Complex and Comparison with the p300 Taz2-p53 TAD1 Complex | |
3BIY | 1.7 | Crystal structure of p300 histone acetyltransferase domain in complex with a bisubstrate inhibitor, Lys-CoA |
3I3J | 2.33 | Crystal Structure of the Bromodomain of Human EP300 |
3IO2 | 2.5 | Crystal structure of the Taz2 domain of p300 |
3P57 | 2.1921 | Crystal structure of the p300 TAZ2 domain bound to MEF2 on DNA |
3T92 | 1.5 | Crystal structure of the Taz2:C/EBPepsilon-TAD chimera protein |
4BHW | 2.799 | Structural basis for autoinhibition of the acetyltransferase activity of p300 |
4PZR | 2.099 | Crystal structure of p300 histone acetyltransferase domain in complex with Coenzyme A |
4PZS | 1.94 | Crystal structure of p300 histone acetyltransferase domain in complex with Acetyl-Coenzyme A |
4PZT | 2.8 | Crystal structure of p300 histone acetyltransferase domain in complex with an inhibitor, Acetonyl-Coenzyme A |
5BT3 | 1.05 | Crystal structure of EP300 bromodomain in complex with SGC-CBP30 chemical probe |
5KJ2 | 1.95 | The novel p300/CBP inhibitor A-485 uncovers a unique mechanism of action to target AR in castrate resistant prostate cancer |
5LKT | 2.04 | Crystal structure of the p300 acetyltransferase catalytic core with butyryl-coenzyme A. |
5LKU | 3.5 | Crystal structure of the p300 acetyltransferase catalytic core with coenzyme A. |
5LKX | 2.52 | Crystal structure of the p300 acetyltransferase catalytic core with propionyl-coenzyme A. |
5LKZ | 2.5 | Crystal structure of the p300 acetyltransferase catalytic core with crotonyl-coenzyme A. |
5LPK | 2.1 | Crystal structure of the bromodomain of human EP300 bound to the inhibitor XDM1 |
5LPM | 1.5 | Crystal structure of the bromodomain of human Ep300 bound to the inhibitor XDM3d |
5NU5 | 1.6 | Crystal structure of the human bromodomain of EP300 bound to the inhibitor XDM-CBP |
5XZC | 10.7 | Cryo-EM structure of p300-p53 protein complex |
6DS6 | 1.95 | Crystal structure of p300 ZZ domain in complex with histone H3 peptide |
6FGN | Solution Structure of p300Taz2-p63TA | |
6FGS | Solution structure of p300Taz2-p73TA1 | |
6GYR | 3.1 | Transcription factor dimerization activates the p300 acetyltransferase |
6GYT | 2.5 | Transcription factor dimerization activates the p300 acetyltransferase |
6K4N | 9.8 | Cryo-EM structure of p300 |
6PF1 | 2.32 | Crystal structure of the p300 acetyltransferase domain with allosteric inhibitor CPI-090 and CoA |
6PGU | 1.72 | Crystal structure of the p300 acetyltransferase domain with allosteric inhibitor CPI-076 and CoA |
6V8B | 3.13 | Crystal structure of the p300 acetyltransferase domain with AcCoA competitive inhibitor 1 |
6V8K | 1.84 | Crystal structure of the p300 acetyltransferase domain with peptide-competitive inhibitor 2 |
6V8N | 2.3 | Crystal structure of the p300 acetyltransferase domain with AcCoA competitive inhibitor 17 |
6V90 | 2.04 | Crystal structure of the p300 acetyltransferase domain with AcCoA competitive inhibitor 12 |
7LJE | 2.607 | Discovery of Spirohydantoins as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone Acetyltransferases |
7QGS | 2.0 | Crystal structure of p300 CH1 domain in complex with CITIF (a CITED2-HIF-1alpha hybrid) |
7SS8 | 2.15 | Human P300 complexed with a proline-based inhibitor |
7SSK | 2.36 | Human P300 complexed with a glycine-based inhibitor |
7SZQ | 2.8 | Human P300 complexed with an azaindazole inhibitor |
7VHY | 2.3 | Crystal structure of EP300 HAT domain in complex with compound (+)-3 |
7VHZ | 2.0 | Crystal structure of EP300 HAT domain in complex with compound 7 |
7VI0 | 2.1 | Crystal structure of EP300 HAT domain in complex with compound 11 |
7W9V | 3.95 | Cryo-EM structure of nucleosome in complex with p300 acetyltransferase catalytic core (complex I) |
8GZC | 2.0 | Crystal structure of EP300 HAT domain in complex with compound 10 |
GO ontology | GO term | GO description |
---|---|---|
Biological Process | GO:0030183 | B cell differentiation |
Biological Process | GO:0018076 | N-terminal peptidyl-lysine acetylation |
Biological Process | GO:0009887 | animal organ morphogenesis |
Biological Process | GO:0006915 | apoptotic process |
Biological Process | GO:0002209 | behavioral defense response |
Biological Process | GO:0007049 | cell cycle |
Biological Process | GO:0034644 | cellular response to UV |
Biological Process | GO:0007623 | circadian rhythm |
Biological Process | GO:0060325 | face morphogenesis |
Biological Process | GO:0045444 | fat cell differentiation |
Biological Process | GO:0007507 | heart development |
Biological Process | GO:0016573 | histone acetylation |
Biological Process | GO:0018393 | internal peptidyl-lysine acetylation |
Biological Process | GO:0006475 | internal protein amino acid acetylation |
Biological Process | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
Biological Process | GO:0007611 | learning or memory |
Biological Process | GO:0030324 | lung development |
Biological Process | GO:0010742 | macrophage derived foam cell differentiation |
Biological Process | GO:0035855 | megakaryocyte development |
Biological Process | GO:0035264 | multicellular organism growth |
Biological Process | GO:0045721 | negative regulation of gluconeogenesis |
Biological Process | GO:0031333 | negative regulation of protein-containing complex assembly |
Biological Process | GO:0000122 | negative regulation of transcription by RNA polymerase II |
Biological Process | GO:0007399 | nervous system development |
Biological Process | GO:0018394 | peptidyl-lysine acetylation |
Biological Process | GO:0140067 | peptidyl-lysine butyrylation |
Biological Process | GO:0140066 | peptidyl-lysine crotonylation |
Biological Process | GO:0061921 | peptidyl-lysine propionylation |
Biological Process | GO:0030220 | platelet formation |
Biological Process | GO:0043923 | positive regulation by host of viral transcription |
Biological Process | GO:0051091 | positive regulation of DNA-binding transcription factor activity |
Biological Process | GO:0045893 | positive regulation of DNA-templated transcription |
Biological Process | GO:0051092 | positive regulation of NF-kappaB transcription factor activity |
Biological Process | GO:1901224 | positive regulation of NIK/NF-kappaB signaling |
Biological Process | GO:1905636 | positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding |
Biological Process | GO:0010976 | positive regulation of neuron projection development |
Biological Process | GO:0032092 | positive regulation of protein binding |
Biological Process | GO:0042307 | positive regulation of protein import into nucleus |
Biological Process | GO:0046427 | positive regulation of receptor signaling pathway via JAK-STAT |
Biological Process | GO:0045944 | positive regulation of transcription by RNA polymerase II |
Biological Process | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway |
Biological Process | GO:0006473 | protein acetylation |
Biological Process | GO:0031648 | protein destabilization |
Biological Process | GO:0050821 | protein stabilization |
Biological Process | GO:0060765 | regulation of androgen receptor signaling pathway |
Biological Process | GO:0010506 | regulation of autophagy |
Biological Process | GO:1900034 | regulation of cellular response to heat |
Biological Process | GO:0006110 | regulation of glycolytic process |
Biological Process | GO:0010821 | regulation of mitochondrion organization |
Biological Process | GO:1901796 | regulation of signal transduction by p53 class mediator |
Biological Process | GO:0090043 | regulation of tubulin deacetylation |
Biological Process | GO:0043627 | response to estrogen |
Biological Process | GO:0001666 | response to hypoxia |
Biological Process | GO:0007519 | skeletal muscle tissue development |
Biological Process | GO:0001756 | somitogenesis |
Biological Process | GO:0002223 | stimulatory C-type lectin receptor signaling pathway |
Biological Process | GO:0036268 | swimming |
Biological Process | GO:0001966 | thigmotaxis |
Biological Process | GO:0006366 | transcription by RNA polymerase II |
Biological Process | GO:0045815 | transcription initiation-coupled chromatin remodeling |
Molecular Function | GO:0003677 | DNA binding |
Molecular Function | GO:0140297 | DNA-binding transcription factor binding |
Molecular Function | GO:0051059 | NF-kappaB binding |
Molecular Function | GO:0061629 | RNA polymerase II-specific DNA-binding transcription factor binding |
Molecular Function | GO:0097677 | STAT family protein binding |
Molecular Function | GO:0016407 | acetyltransferase activity |
Molecular Function | GO:0016746 | acyltransferase activity |
Molecular Function | GO:0008013 | beta-catenin binding |
Molecular Function | GO:0031490 | chromatin DNA binding |
Molecular Function | GO:0003682 | chromatin binding |
Molecular Function | GO:0003684 | damaged DNA binding |
Molecular Function | GO:0008047 | enzyme activator activity |
Molecular Function | GO:0004857 | enzyme inhibitor activity |
Molecular Function | GO:0044013 | histone H2B acetyltransferase activity |
Molecular Function | GO:0010484 | histone H3 acetyltransferase activity |
Molecular Function | GO:0140908 | histone H3K122 acetyltransferase activity |
Molecular Function | GO:0010485 | histone H4 acetyltransferase activity |
Molecular Function | GO:0004402 | histone acetyltransferase activity |
Molecular Function | GO:0140069 | histone butyryltransferase activity |
Molecular Function | GO:0140068 | histone crotonyltransferase activity |
Molecular Function | GO:0120301 | histone lactyltransferase activity |
Molecular Function | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
Molecular Function | GO:0050681 | nuclear androgen receptor binding |
Molecular Function | GO:0016922 | nuclear receptor binding |
Molecular Function | GO:0002039 | p53 binding |
Molecular Function | GO:0106226 | peptide 2-hydroxyisobutyryltransferase activity |
Molecular Function | GO:0034212 | peptide N-acetyltransferase activity |
Molecular Function | GO:0140065 | peptide butyryltransferase activity |
Molecular Function | GO:0061733 | peptide-lysine-N-acetyltransferase activity |
Molecular Function | GO:0097157 | pre-mRNA intronic binding |
Molecular Function | GO:0061920 | protein propionyltransferase activity |
Molecular Function | GO:0048156 | tau protein binding |
Molecular Function | GO:0003713 | transcription coactivator activity |
Molecular Function | GO:0001223 | transcription coactivator binding |
Molecular Function | GO:0001221 | transcription coregulator binding |
Molecular Function | GO:0008270 | zinc ion binding |
Cellular Component | GO:0000785 | chromatin |
Cellular Component | GO:0005737 | cytoplasm |
Cellular Component | GO:0005829 | cytosol |
Cellular Component | GO:0000123 | histone acetyltransferase complex |
Cellular Component | GO:0005654 | nucleoplasm |
Cellular Component | GO:0005634 | nucleus |
Cellular Component | GO:0032993 | protein-DNA complex |
Cellular Component | GO:0005667 | transcription regulator complex |
InterPro | InterPro name |
---|---|
IPR000197 | Zinc finger, TAZ-type |
IPR000433 | Zinc finger, ZZ-type |
IPR001487 | Bromodomain |
IPR003101 | Coactivator CBP, KIX domain |
IPR009110 | Nuclear receptor coactivator, interlocking |
IPR010303 | CREB-binding protein/p300, atypical RING domain |
IPR013083 | Zinc finger, RING/FYVE/PHD-type |
IPR013178 | Histone acetyltransferase Rtt109/CBP |
IPR014744 | Nuclear receptor coactivator, CREB-bp-like, interlocking |
IPR018359 | Bromodomain, conserved site |
IPR031162 | CBP/p300-type histone acetyltransferase domain |
IPR035898 | TAZ domain superfamily |
IPR036427 | Bromodomain-like superfamily |
IPR036529 | Coactivator CBP, KIX domain superfamily |
IPR037073 | Nuclear receptor coactivator, CREB-bp-like, interlocking domain superfamily |
IPR038547 | CBP/p300, atypical RING domain superfamily |
IPR043145 | Zinc finger, ZZ-type superfamily |
Pfam | Pfam name |
---|---|
PF00439 | Bromodomain |
PF00569 | Zinc finger, ZZ type |
PF02135 | TAZ zinc finger |
PF02172 | KIX domain |
PF06001 | CREB-binding protein/p300, atypical RING domain |
PF08214 | Histone acetylation protein |
PF09030 | Creb binding |
Reactome | Reactome Name | Node type | Reactome Root | Reactome Root Name |
---|---|---|---|---|
R-HSA-1234158 | Regulation of gene expression by Hypoxia-inducible Factor | Leaf | R-HSA-8953897 | Cellular responses to stimuli |
R-HSA-1368082 | RORA activates gene expression | Leaf | R-HSA-400253 | Circadian Clock |
R-HSA-156711 | Polo-like kinase mediated events | Leaf | R-HSA-1640170 | Cell Cycle |
R-HSA-1912408 | Pre-NOTCH Transcription and Translation | Leaf | R-HSA-162582 | Signal Transduction |
R-HSA-1989781 | PPARA activates gene expression | Leaf | R-HSA-1430728 | Metabolism |
R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex | Internal node | R-HSA-162582 | Signal Transduction |
R-HSA-210744 | Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | Leaf | R-HSA-1266738 | Developmental Biology |
R-HSA-2122947 | NOTCH1 Intracellular Domain Regulates Transcription | Leaf | R-HSA-162582 | Signal Transduction |
R-HSA-2173796 | SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-2197563 | NOTCH2 intracellular domain regulates transcription | Leaf | R-HSA-162582 | Signal Transduction |
R-HSA-2644606 | Constitutive Signaling by NOTCH1 PEST Domain Mutants | Leaf | R-HSA-1643685 | Disease |
R-HSA-2894862 | Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | Leaf | R-HSA-1643685 | Disease |
R-HSA-3134973 | LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | Leaf | R-HSA-168256 | Immune System |
R-HSA-3214847 | HATs acetylate histones | Leaf | R-HSA-4839726 | Chromatin organization |
R-HSA-3371568 | Attenuation phase | Leaf | R-HSA-8953897 | Cellular responses to stimuli |
R-HSA-381340 | Transcriptional regulation of white adipocyte differentiation | Leaf | R-HSA-1266738 | Developmental Biology |
R-HSA-3899300 | SUMOylation of transcription cofactors | Leaf | R-HSA-392499 | Metabolism of proteins |
R-HSA-400253 | Circadian Clock | Root | R-HSA-400253 | Circadian Clock |
R-HSA-5250924 | B-WICH complex positively regulates rRNA expression | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogenesis | Leaf | R-HSA-1266738 | Developmental Biology |
R-HSA-5621575 | CD209 (DC-SIGN) signaling | Leaf | R-HSA-168256 | Immune System |
R-HSA-5689901 | Metalloprotease DUBs | Leaf | R-HSA-392499 | Metabolism of proteins |
R-HSA-6781823 | Formation of TC-NER Pre-Incision Complex | Leaf | R-HSA-73894 | DNA Repair |
R-HSA-6781827 | Transcription-Coupled Nucleotide Excision Repair (TC-NER) | Internal node | R-HSA-73894 | DNA Repair |
R-HSA-6782135 | Dual incision in TC-NER | Leaf | R-HSA-73894 | DNA Repair |
R-HSA-6782210 | Gap-filling DNA repair synthesis and ligation in TC-NER | Leaf | R-HSA-73894 | DNA Repair |
R-HSA-6804114 | TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-6804758 | Regulation of TP53 Activity through Acetylation | Internal node | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-6804760 | Regulation of TP53 Activity through Methylation | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-6811555 | PI5P Regulates TP53 Acetylation | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-8866907 | Activation of the TFAP2 (AP-2) family of transcription factors | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-8936459 | RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-8939243 | RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-8941856 | RUNX3 regulates NOTCH signaling | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-8941858 | Regulation of RUNX3 expression and activity | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-8951936 | RUNX3 regulates p14-ARF | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-9013508 | NOTCH3 Intracellular Domain Regulates Transcription | Leaf | R-HSA-162582 | Signal Transduction |
R-HSA-9013695 | NOTCH4 Intracellular Domain Regulates Transcription | Leaf | R-HSA-162582 | Signal Transduction |
R-HSA-9018519 | Estrogen-dependent gene expression | Leaf | R-HSA-162582 | Signal Transduction |
R-HSA-9029569 | NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | Leaf | R-HSA-162582 | Signal Transduction |
R-HSA-9031628 | NGF-stimulated transcription | Leaf | R-HSA-162582 | Signal Transduction |
R-HSA-918233 | TRAF3-dependent IRF activation pathway | Leaf | R-HSA-168256 | Immune System |
R-HSA-933541 | TRAF6 mediated IRF7 activation | Leaf | R-HSA-168256 | Immune System |
R-HSA-9614657 | FOXO-mediated transcription of cell death genes | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-9616222 | Transcriptional regulation of granulopoiesis | Leaf | R-HSA-1266738 | Developmental Biology |
R-HSA-9617629 | Regulation of FOXO transcriptional activity by acetylation | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-9701898 | STAT3 nuclear events downstream of ALK signaling | Leaf | R-HSA-162582 | Signal Transduction |
R-HSA-9707616 | Heme signaling | Leaf | R-HSA-8953897 | Cellular responses to stimuli |
R-HSA-9735871 | SARS-CoV-1 targets host intracellular signalling and regulatory pathways | Leaf | R-HSA-1643685 | Disease |
R-HSA-9759194 | Nuclear events mediated by NFE2L2 | Internal node | R-HSA-8953897 | Cellular responses to stimuli |
R-HSA-9793380 | Formation of paraxial mesoderm | Internal node | R-HSA-1266738 | Developmental Biology |
R-HSA-9818027 | NFE2L2 regulating anti-oxidant/detoxification enzymes | Leaf | R-HSA-8953897 | Cellular responses to stimuli |
R-HSA-9818028 | NFE2L2 regulates pentose phosphate pathway genes | Leaf | R-HSA-8953897 | Cellular responses to stimuli |
Location | ECO term | Pubmed |
---|---|---|
Chromosome | ECO:0000269 | PubMed:14645221 |
Chromosome | ECO:0000269 | PubMed:25818647 |
Cytoplasm | ECO:0000269 | PubMed:12929931 |
Cytoplasm | ECO:0000269 | PubMed:20940255 |
Nucleus | ECO:0000269 | PubMed:12929931 |
Nucleus | ECO:0000269 | PubMed:14645221 |
Nucleus | ECO:0000269 | PubMed:16219772 |
Nucleus | ECO:0000269 | PubMed:16574662 |
Nucleus | ECO:0000269 | PubMed:17761950 |
Nucleus | ECO:0000269 | PubMed:20940255 |
Nucleus | ECO:0000269 | PubMed:25593309 |
HPO ID | HPO name |
---|---|
HP:0002311 | Incoordination |
HP:0001347 | Hyperreflexia |
HP:0002414 | Spina bifida |
HP:0001762 | Talipes equinovarus |
HP:0000047 | Hypospadias |
HP:0001601 | Laryngomalacia |
HP:0008897 | Postnatal growth retardation |
HP:0005280 | Depressed nasal bridge |
HP:0002664 | Neoplasm |
HP:0005484 | Secondary microcephaly |
HP:0000518 | Cataract |
HP:0000494 | Downslanted palpebral fissures |
HP:0002098 | Respiratory distress |
HP:0031251 | Abnormal subclavian artery morphology |
HP:0001999 | Abnormal facial shape |
HP:0002002 | Deep philtrum |
HP:0002219 | Facial hypertrichosis |
HP:0000405 | Conductive hearing impairment |
HP:0000049 | Shawl scrotum |
HP:0002750 | Delayed skeletal maturation |
HP:0000219 | Thin upper lip vermilion |
HP:0000446 | Narrow nasal bridge |
HP:0000218 | High palate |
HP:0011917 | Short 5th toe |
HP:0001561 | Polyhydramnios |
HP:0000520 | Proptosis |
HP:0000347 | Micrognathia |
HP:0012758 | Neurodevelopmental delay |
HP:0000175 | Cleft palate |
HP:0025269 | Panic attack |
HP:0031546 | Cardiac conduction abnormality |
HP:0000582 | Upslanted palpebral fissure |
HP:0001763 | Pes planus |
HP:0001747 | Accessory spleen |
HP:0011304 | Broad thumb |
HP:0011470 | Nasogastric tube feeding in infancy |
HP:0000722 | Compulsive behaviors |
HP:0001428 | Somatic mutation |
HP:0410263 | Brain imaging abnormality |
HP:0000369 | Low-set ears |
HP:0002205 | Recurrent respiratory infections |
HP:0008752 | Laryngeal cartilage malformation |
HP:0010314 | Premature thelarche |
HP:0031207 | Hepatic hemangioma |
HP:0001212 | Prominent fingertip pads |
HP:0000717 | Autism |
HP:0003593 | Infantile onset |
HP:0001627 | Abnormal heart morphology |
HP:0000010 | Recurrent urinary tract infections |
HP:0000932 | Abnormal posterior cranial fossa morphology |
HP:0005301 | Persistent left superior vena cava |
HP:0001634 | Mitral valve prolapse |
HP:0001518 | Small for gestational age |
HP:0002870 | Obstructive sleep apnea |
HP:0000729 | Autistic behavior |
HP:0002308 | Chiari malformation |
HP:0100716 | Self-injurious behavior |
HP:0002835 | Aspiration |
HP:0001956 | Truncal obesity |
HP:0002000 | Short columella |
HP:0000708 | Atypical behavior |
HP:0000486 | Strabismus |
HP:0011220 | Prominent forehead |
HP:0001256 | Intellectual disability, mild |
HP:0030047 | Abnormal lateral ventricle morphology |
HP:0000316 | Hypertelorism |
HP:0000079 | Abnormality of the urinary system |
HP:0000733 | Abnormal repetitive mannerisms |
HP:0000448 | Prominent nose |
HP:0001647 | Bicuspid aortic valve |
HP:0012368 | Flat face |
HP:0001845 | Overlapping toe |
HP:0003745 | Sporadic |
HP:0002553 | Highly arched eyebrow |
HP:0006200 | Widened distal phalanges |
HP:0002588 | Duodenal ulcer |
HP:0001508 | Failure to thrive |
HP:0002700 | Large foramen magnum |
HP:0000787 | Nephrolithiasis |
HP:0003319 | Abnormality of the cervical spine |
HP:0002019 | Constipation |
HP:0010059 | Broad hallux phalanx |
HP:0002353 | EEG abnormality |
HP:0000260 | Wide anterior fontanel |
HP:0008523 | Posterior helix pit |
HP:0006349 | Agenesis of permanent teeth |
HP:0002341 | Cervical cord compression |
HP:0001273 | Abnormal corpus callosum morphology |
HP:0000252 | Microcephaly |
HP:0009836 | Broad distal phalanx of finger |
HP:0001290 | Generalized hypotonia |
HP:0010621 | Cutaneous syndactyly of toes |
HP:0002099 | Asthma |
HP:0009715 | Papillary cystadenoma of the epididymis |
HP:0002891 | Uterine leiomyosarcoma |
HP:0011947 | Respiratory tract infection |
HP:0002183 | Phonophobia |
HP:0003577 | Congenital onset |
HP:0000689 | Dental malocclusion |
HP:0012448 | Delayed myelination |
HP:0002236 | Frontal upsweep of hair |
HP:0000478 | Abnormality of the eye |
HP:0034227 | Aortic isthmus hypoplasia |
HP:0030890 | Hyperintensity of cerebral white matter on MRI |
HP:0000006 | Autosomal dominant inheritance |
HP:0001274 | Agenesis of corpus callosum |
HP:0000574 | Thick eyebrow |
HP:0000273 | Facial grimacing |
HP:0002866 | Hypoplastic iliac wing |
HP:0000752 | Hyperactivity |
HP:0001852 | Sandal gap |
HP:0000189 | Narrow palate |
HP:0002858 | Meningioma |
HP:0002194 | Delayed gross motor development |
HP:0000270 | Delayed cranial suture closure |
HP:0000034 | Hydrocele testis |
HP:0000077 | Abnormality of the kidney |
HP:0000028 | Cryptorchidism |
HP:0000508 | Ptosis |
HP:0010674 | Abnormal curvature of the vertebral column |
HP:0001181 | Adducted thumb |
HP:0009765 | Low hanging columella |
HP:0000540 | Hypermetropia |
HP:0100852 | Abnormal fear/anxiety-related behavior |
HP:0005306 | Capillary hemangioma |
HP:0000490 | Deeply set eye |
HP:0002999 | Patellar dislocation |
HP:0011087 | Talon cusp |
HP:0010105 | Short first metatarsal |
HP:0001642 | Pulmonic stenosis |
HP:0000126 | Hydronephrosis |
HP:0000444 | Convex nasal ridge |
HP:0001382 | Joint hypermobility |
HP:0000718 | Aggressive behavior |
HP:0000559 | Corneal scarring |
HP:0001250 | Seizure |
HP:0000501 | Glaucoma |
HP:0001249 | Intellectual disability |
HP:0002697 | Parietal foramina |
HP:0000678 | Dental crowding |
HP:0003396 | Syringomyelia |
HP:0000670 | Carious teeth |
HP:0006753 | Neoplasm of the stomach |
HP:0001909 | Leukemia |
HP:0002007 | Frontal bossing |
HP:0002869 | Flared iliac wing |
HP:0001385 | Hip dysplasia |
HP:0006740 | Transitional cell carcinoma of the bladder |
HP:0000957 | Cafe-au-lait spot |
HP:0007086 | Social and occupational deterioration |
HP:0011229 | Broad eyebrow |
HP:0000319 | Smooth philtrum |
HP:0012450 | Chronic constipation |
HP:0010066 | Duplication of phalanx of hallux |
HP:0006297 | Enamel hypoplasia |
HP:0010051 | Deviation of the hallux |
HP:0030434 | Pilomatrixoma |
HP:0001263 | Global developmental delay |
HP:0000668 | Hypodontia |
HP:0000639 | Nystagmus |
HP:0010562 | Keloids |
HP:0000388 | Otitis media |
HP:0000321 | Square face |
HP:0000327 | Hypoplasia of the maxilla |
HP:0000278 | Retrognathia |
HP:0008107 | Plantar crease between first and second toes |
HP:0001513 | Obesity |
HP:0005363 | Humoral immunodeficiency |
HP:0005322 | Prominent nasal septum |
HP:0001388 | Joint laxity |
HP:0001252 | Hypotonia |
HP:0008689 | Bilateral cryptorchidism |
HP:0000527 | Long eyelashes |
HP:0000767 | Pectus excavatum |
HP:0001643 | Patent ductus arteriosus |
HP:0001371 | Flexion contracture |
HP:0000589 | Coloboma |
HP:0000076 | Vesicoureteral reflux |
HP:0009778 | Short thumb |
HP:0000119 | Abnormality of the genitourinary system |
HP:0031936 | Delayed ability to walk |
HP:0000954 | Single transverse palmar crease |
HP:0012745 | Short palpebral fissure |
HP:0011682 | Perimembranous ventricular septal defect |
HP:0030680 | Abnormality of cardiovascular system morphology |
HP:0008872 | Feeding difficulties in infancy |
HP:0005374 | Cellular immunodeficiency |
HP:0000358 | Posteriorly rotated ears |
HP:0002650 | Scoliosis |
HP:0003083 | Dislocated radial head |
HP:0004209 | Clinodactyly of the 5th finger |
HP:0011335 | Frontal hirsutism |
HP:0001344 | Absent speech |
HP:0000756 | Agoraphobia |
HP:0002705 | High, narrow palate |
HP:0001629 | Ventricular septal defect |
HP:0002162 | Low posterior hairline |
HP:0010775 | Vascular ring |
HP:0001655 | Patent foramen ovale |
HP:0010442 | Polydactyly |
HP:0007099 | Chiari type I malformation |
HP:0000407 | Sensorineural hearing impairment |
HP:0000712 | Emotional lability |
HP:0000160 | Narrow mouth |
HP:0002317 | Unsteady gait |
HP:0011968 | Feeding difficulties |
HP:0000581 | Blepharophimosis |
HP:0011094 | Increased overbite |
HP:0000695 | Natal tooth |
HP:0001128 | Trichiasis |
HP:0005895 | Radial deviation of thumb terminal phalanx |
HP:0004322 | Short stature |
HP:0000365 | Hearing impairment |
HP:0002090 | Pneumonia |
HP:0004411 | Deviated nasal septum |
HP:0009834 | Abnormal proximal phalanx morphology of the hand |
HP:0002020 | Gastroesophageal reflux |
HP:0000431 | Wide nasal bridge |
HP:0002370 | Poor coordination |
HP:0001680 | Coarctation of aorta |
HP:0020206 | Simple ear |
HP:0100710 | Impulsivity |
HP:0001511 | Intrauterine growth retardation |
HP:0000286 | Epicanthus |
HP:0005584 | Renal cell carcinoma |
HP:0004383 | Hypoplastic left heart |
HP:0000750 | Delayed speech and language development |
HP:0001650 | Aortic valve stenosis |
HP:0000742 | Self-mutilation |
HP:0006716 | Hereditary nonpolyposis colorectal carcinoma |
HP:0001042 | High axial triradius |
HP:0000736 | Short attention span |
HP:0003298 | Spina bifida occulta |
HP:0000293 | Full cheeks |
HP:0001159 | Syndactyly |
HP:0010055 | Broad hallux |
HP:0000579 | Nasolacrimal duct obstruction |
HP:0005743 | Avascular necrosis of the capital femoral epiphysis |
HP:0002788 | Recurrent upper respiratory tract infections |
HP:0001007 | Hirsutism |
HP:0000294 | Low anterior hairline |
HP:0000735 | Impaired social interactions |
HP:0000387 | Absent earlobe |
HP:0002566 | Intestinal malrotation |
HP:0011069 | Supernumerary tooth |
HP:0001631 | Atrial septal defect |
HP:0001510 | Growth delay |
Disease name | MONDO ID | ICD10 | ICD10 chapter | OMIM | Orphanet |
---|---|---|---|---|---|
squamous cell lung carcinoma | MONDO:0005097 | C34 | chapter2, Neoplasms | ||
colorectal cancer | MONDO:0005575 | C18 | chapter2, Neoplasms | OMIM:114500 | Orphanet:466667 |
bladder transitional cell carcinoma | MONDO:0005611 | C64 | chapter2, Neoplasms | ||
bladder transitional cell carcinoma | MONDO:0005611 | C67 | chapter2, Neoplasms | ||
bladder transitional cell carcinoma | MONDO:0005611 | C68 | chapter2, Neoplasms | ||
medulloblastoma | MONDO:0007959 | C71 | chapter2, Neoplasms | OMIM:155255 | Orphanet:616 |
rubinstein-taybi syndrome due to crebbp mutations | MONDO:0008393 | Q87 | chapter17, Congenital malformations, deformations and chromosomal abnormalities | OMIM:180849 | Orphanet:353277 |
head and neck squamous cell carcinoma | MONDO:0010150 | C76 | chapter2, Neoplasms | OMIM:275355 | Orphanet:67037 |
rubinstein-taybi syndrome due to ep300 haploinsufficiency | MONDO:0013364 | Q87 | chapter17, Congenital malformations, deformations and chromosomal abnormalities | OMIM:613684 | Orphanet:353284 |
carcinoma of esophagus | MONDO:0019086 | C15 | chapter2, Neoplasms | Orphanet:70482 | |
menke-hennekam syndrome 2 | MONDO:0020769 | Q87 | chapter17, Congenital malformations, deformations and chromosomal abnormalities | OMIM:618333 | |
uterine cervix neoplasm | MONDO:0021230 | - | - |